Daniel P. Cahill

Resolving the phylogenetic origin of glioblastoma via multifocal genomic analysis of pre-treatment and treatment-resistant autopsy specimens

Gad Getz, Ignaty Leshchiner, Tracy T. Batchelor, 2017, npj Precision Oncology.

An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma

Mariella G. Filbin, McKenzie L. Shaw, Lisa Mayr, 2019, Cell.

Butterfly glioblastomas: a retrospective review and qualitative assessment of outcomes

Sujit S. Prabhu, Nicholas B. Levine, Dima Suki, 2012, Journal of Neuro-Oncology.

MSH6 Mutations Arise in Glioblastomas during Temozolomide Therapy and Mediate Temozolomide Resistance

Stephen Yip, David N. Louis, A. John Iafrate, 2009, Clinical Cancer Research.

Genetic instability and darwinian selection in tumours

Bert Vogelstein, Kenneth W. Kinzler, Christoph Lengauer, 1999 .

Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells

Simon Kasif, Miguel N. Rivera, Aviv Regev, 2014, Cell.

Defining Glioblastoma Resectability Through the Wisdom of the Crowd: A Proof-of-Principle Study

David W. Roberts, Oren Sagher, Theodore H. Schwartz, 2016, Neurosurgery.

Mutations of mitotic checkpoint genes in human cancers

Bert Vogelstein, Kenneth W. Kinzler, Christoph Lengauer, 1998, Nature.